Whole-genome sequencing identifies responders to Pembrolizumab in relapse/refractory natural-killer/T cell lymphoma.
作者信息
Lim Jing Quan, Huang Dachuan, Tang Tiffany, Tan Daryl, Laurensia Yurike, Peng Rou-Jun, Wong Esther Kam Yin, Cheah Daryl Ming Zhe, Chia Burton Kuan Hui, Iqbal Jabed, Grigoropoulos Nicholas Francis, Nairismägi Maarja-Liisa, Ng Cedric Chuan Young, Rajasegaran Vikneswari, Hong Huangming, Kim Seok Jin, Cho Junhun, Tse Eric, Mow Benjamin, Cai Qi-Chun, Poon Li-Mei, Cai Qing-Qing, Tan Jing, Chan Jason Yongsheng, Lim Johnathan Xiande, Goh Yeow Tee, Phipps Colin, Rötzschke Olaf, Cheng Chee Leong, Ha Jeslin Chian Hung, Khoo Lay Poh, Loh Yvonne Su Ming, Au-Yeung Rex, Chan Thomas Sau-Yan, Kwong Yok-Lam, Hwang William, Kim Won Seog, Bei Jin-Xin, Lin Tongyu, Ong Choon Kiat, Lim Soon Thye
机构信息
State Key Laboratory of Oncology in South China, Collaborative Innovation Center of Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, 510060, China.
Lymphoma Genomic Translational Research Laboratory, Cellular and Molecular Research, National Cancer Centre Singapore, 11 Hospital Drive, Singapore, 169610, Singapore.
出版信息
Leukemia. 2020 Dec;34(12):3413-3419. doi: 10.1038/s41375-020-1000-0. Epub 2020 Aug 5.
Zotero 插件